| Literature DB >> 31428165 |
Enyam Komla Amewuho Morny1, Samuel Bert Boadi-Kusi1, Stephen Ocansey1, Samuel Kyei1, Kwame Yeboah1, Maureen Adanna Mmaduagwu1.
Abstract
Purpose: The aim of this study was to analyse eye health delivery in Ghana and examine the progress towards achieving VISION 2020 indicator targets.Entities:
Mesh:
Year: 2019 PMID: 31428165 PMCID: PMC6679876 DOI: 10.1155/2019/3813298
Source DB: PubMed Journal: J Environ Public Health ISSN: 1687-9805
Figure 1Map of Ghana showing the 10 administrative regions and their capital cities (available at https://goo.gl/images/8FwnbY; accessed 22/12/2018).
Population-based studies on prevalence of blindness in Ghana (presenting VA).
| Study | Year | Location | Prevalence of MSVI and principal causes | Prevalence of blindness and its principal causes |
|---|---|---|---|---|
| Moll et al. [ | 1991 | Wenchi | 3.7% | 1.7% |
| Cataract (52%), refractive error (24%), nonglaucomotous optic atrophy (2%), vascular retinopathy (2%) | Cataract (63%), onchocerciasis (13%), corneal opacity (8%), refractive error (4%), phthisis (4%) | |||
| Guzek et al. [ | 2001 | Ho, Hohoe, Kpando | 15.0% | 2.8% |
| Cataract (54%), glaucoma (21%) and refractive error (17%), retinal disorders (9%); optic atrophy (8.8%), iatrogenic (3.9%) | ||||
| Budenz et al. [ | 2005 | Tema | 11.3% | 1.2% |
| Refractive error 61%, cataract 21%, glaucoma (5%), corneal opacities 3%, retinal disease 3% | Refractive error (35%), cataract (28%), glaucoma (14%), corneal opacities (6%), retinal disease (6%) | |||
| Wiafe et al. [ | 2015 | Whole of Ghana | 3.0% | 0.9% |
| Refractive error (44.4%), cataract (42.2%), posterior segment 8.9%, glaucoma (2.2%) and corneal opacities (2.2%) | Cataract (55%), glaucoma (19%), posterior segment diseases (13%), corneal opacities (11%) | |||
MSVI: moderate to severe visual impairment, VA < 6/18 to 3/60.
Figure 2Cataract surgical rates in the 10 regions of Ghana compared to the WHO target in 2016. AR: Ashanti Region; BAR: Brong-Ahafo Region; CR: Central Region; ER: Eastern Region; GAR: Greater Accra Region; NR: Northern Region; UE: Upper East Region; UW: Upper West Region; VR: Volta Region; WR: Western Region.
Figure 3Number of eye health personnel in Ghana segregated according to regions in 2017. Abbreviations for regions are the same as in Figure 2. NB: number of optometrists includes private and public sector. Sources: NECU registers of ophthalmologists and ophthalmic nurses; GOA register of optometrists.
Figure 4Number of eye health facilities in Ghana in 2017. CHAG: Christian Health Association Of Ghana; GHS: Ghana Health Service. Abbreviations for regions are the same as in Figure 2. Source: National Eye Care Unit. The number of GHS facilities in GAR includes the one teaching hospital and two quasigovernment facilities. The number of GHS facilities in AR and CR includes one teaching hospital each.
Distribution of eye care facilities who responded to the survey by regions in Ghana.
| Region | Tertiary | Regional | Metro | Mun/Dist | CHAG | Total no. of facilities |
|---|---|---|---|---|---|---|
| Ashanti | — | 1 | 2 | 1 | 3 | 7 |
| Brong-Ahafo | — | — | — | 1 | 2 | 3 |
| Central | 1 | 1 | 2 | 3 | 3 | 10 |
| Eastern | — | — | 1 | 5 | 1 | 7 |
| Greater Accra | 1 | 1 | 4 | 7 | 2 | 15 |
| Northern | 1 | 1 | 3 | 2 | 3 | 10 |
| Upper East | — | — | — | 1 | — | 1 |
| Upper West | — | — | 1 | — | 1 | 2 |
| Volta | — | 1 | — | 3 | — | 4 |
| Western | — | 1 | 1 | 2 | — | 4 |
| Total | 3 | 6 | 14 | 25 | 15 | 63 |
Comprises two teaching hospitals and 1 quasigovernment facility. Metro: metropolitan hospitals; Mun/Dist: municipal/district hospitals; CHAG: Christian Health Association of Ghana facilities.
List of essential equipment available in the surveyed facilities.
| Category of equipment | Listed equipment | Type of facility | ||||
|---|---|---|---|---|---|---|
| Tertiary ( | Regional ( | Metro ( | Mun/Dist ( | CHAG ( | ||
| Refraction | Autorefractor | 1 | 2 | 4 | 3 | 3 |
| Lensometer | 2 | 4 | 6 | 6 | 6 | |
| Streak retinoscope | 3 | 4 | 4 | 10 | 8 | |
| Test type (distance) | 3 | 6 | 13 | 23 | 15 | |
| Test type (near) | 3 | 6 | 12 | 23 | 15 | |
| Trail frame | 3 | 6 | 13 | 22 | 15 | |
| Trial lens set | 3 | 6 | 14 | 22 | 15 | |
|
| ||||||
| Cataract surgery | A-scan | 1 | 1 | 1 | 0 | 1 |
| Applanation tonometer | 2 | 6 | 8 | 11 | 11 | |
| Autorefractor | 1 | 2 | 4 | 3 | 3 | |
| Binocular indirect ophthalmoscope | 2 | 5 | 4 | 2 | 3 | |
| Cataract surgical set | 2 | 5 | 6 | 10 | 8 | |
| Direct ophthalmoscope | 3 | 6 | 14 | 25 | 14 | |
| Gonio lens | 2 | 1 | 2 | 0 | 2 | |
| Head loupe | 3 | 3 | 9 | 17 | 7 | |
| Keratometer | 2 | 1 | 2 | 2 | 4 | |
| Operating microscope | 3 | 5 | 3 | 6 | 6 | |
| Slit lamp biomicroscope | 3 | 6 | 11 | 13 | 12 | |
|
| ||||||
| Glaucoma screening, surgery and follow-up | A-scan | 1 | 1 | 1 | 0 | 1 |
| Applanation tonometer | 2 | 6 | 8 | 11 | 11 | |
| ARGON laser | 0 | 0 | 0 | 0 | 1 | |
| Binocular indirect ophthalmoscope | 2 | 5 | 4 | 2 | 3 | |
| Direct ophthalmoscope | 3 | 6 | 14 | 25 | 14 | |
| Fundus camera | 0 | 1 | 0 | 0 | 0 | |
| Fundus lens | 2 | 1 | 4 | 3 | 4 | |
| Glaucoma set | 1 | 1 | 3 | 1 | 3 | |
| Gonio lens | 2 | 1 | 2 | 0 | 2 | |
| OCT | 0 | 0 | 0 | 0 | 1 | |
| Schiotz tonometer | 2 | 3 | 10 | 13 | 7 | |
| Slit lamp biomicroscope | 3 | 4 | 11 | 13 | 12 | |
| Visual field analyser | 1 | 3 | 2 | 0 | 2 | |
| YAG laser | 1 | 1 | 0 | 0 | 2 | |
|
| ||||||
| Diabetic retinopathy screening | ARGON laser | 0 | 0 | 0 | 0 | 1 |
| Binocular indirect ophthalmoscope | 2 | 5 | 4 | 2 | 3 | |
| Direct ophthalmoscope | 3 | 6 | 14 | 25 | 14 | |
| Fundus camera | 1 | 1 | 0 | 0 | 0 | |
| OCT | 0 | 0 | 0 | 0 | 1 | |
| Visual field analyser | 1 | 3 | 2 | 0 | 2 | |
| YAG laser | 1 | 1 | 0 | 0 | 2 | |
n: total number of facilities at each level.